Baxter International Inc. · NYSE:BAX
Baxter International — Investor Presentation (September 2020)
16 slides from Baxter International's investor presentation, Sep 28, 2020
Slide 1: Fall Shareholder Engagement
Fall Shareholder Engagement Exhibit 99.1 August 2019 Fall Shareholder Engagement Baxter International Inc. October 2020
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter’s financial results, capital allocation activities and principle (including potential business development transactions), corporate governance goals and executive compensation program. The statements are ba
Slide 3: Executive Summary
Executive Summary Business ▪ Leading global medical products company focused on transformative innovation to deliver smarter, more personalized care for patients and providers ▪ Addressing healthcare needs across the continuum of care, our product settings include hospitals, homes, pharmacies, and c
Slide 4: Baxter: A Leading Medical Products Company
Baxter: A Leading Medical Products Company Baxter’s mission to save and sustain lives inspires our work and our commitment to deliver products and services that are essential building blocks of healthcare Global Footprint 2019 Revenue | $11.4B By Global Business By Operating Manufacturing Unit Segme
Slide 5: Top Quartile Goals and Our Strategy
Top Quartile Goals Patient safety and Quality Best place to work Growth through innovation Industry leading performance Our Strategy Strengthen our portfolio and extend our impact through transformative innovation that spans prevention to recovery 5
Slide 6: Executing On Our Strategy: Recent Highlights
Executing On Our Strategy: Recent Highlights Demonstrating Underlying Portfolio Resilience In Dynamic Environment1 ▪ Operational sales decline of (2%) in Q2 represents durability despite >$180 million estimated net negative impact on total sales related to COVID-19 ▪ Adjusted diluted EPS decline of
Slide 7: Prioritizing Financial Flexibility While Driving Value For Shareholders
Prioritizing Financial Flexibility While Driving Value For Shareholders Reinvestment In Business Meeting the needs of patients and providers globally while continuing to invest in long-term innovation and accelerated launch cadence Increased Dividend Announced ~11% increase of quarterly dividend to
Slide 8: Committed Response To The COVID-19 Pandemic
Committed Response To The COVID-19 Pandemic • Boosted capacity and production to address higher demand for: PrisMax and Prismaflex and associated solutions and consumables; Mini-Bag Plus; Spectrum IQ Infusion System and accompanying I.V. sets; I.V. solutions; and injectable drugs Increasing Product
Slide 9: Demonstrating Leadership In Corporate Social Responsibility
Demonstrating Leadership In Corporate Social Responsibility Baxter 2015 – 2020 Corporate Responsibility Priorities and Goals PRODUCT INNOVATION WORKPLACE CULTURE ETHICS AND COMPLIANCE EMPLOYEE HEALTH & SAFETY Improve sustainability and Promote inclusion, diversity and Drive a culture of integrity an
Slide 10: A Recognized Top Employer And Outstanding Corporate Citizen
A Recognized Top Employer And Outstanding Corporate Citizen Serving Our Representative Corporate Ratings Improvements Communities Responsibility Recognition 2018 2019 2020 Human Rights Worldwide Newsweek Disability Equality Index Campaign Foundation America’s Most 3BL Media Best Places to Work for B
Slide 11: Committed To Fostering An Inclusive Work Environment
Committed To Fostering An Inclusive Work Environment Our global inclusion strategy focuses on four key areas: 1 Workforce 2 Workplace 3 Communities 4 Marketplace Recruit and build diverse and Advance our inclusive culture Cultivate strategic and diverse Consider the needs of customers high-performin
Slide 12: Director Skillsets Support Effective Oversight Of Strategy
Director Skillsets Support Effective Oversight Of Strategy We are committed to ongoing director refreshment to ensure our Board has the right skills and background to effectively oversee our strategy and create long-term value for our stockholders Complementary Skillsets JOSÉ ( J O E ) E . ALMEIDA T
Slide 13: Board Leadership Structure
Board Leadership Structure In response to the views expressed by shareholders at our 2020 Annual Meeting, we have committed to enhancing Baxter’s Corporate Governance Guidelines Benefits of Maintaining Current CEO / Chair Role Continued Independent Board Oversight ✓ Leverage Mr. Almeida’s substantia
Slide 14: Executive Compensation Aligned With Strategic Priorities
Executive Compensation Aligned With Strategic Priorities Our focus on pay-for-performance ensures executive compensation is tied to specific annual and long-term performance requirements that create long-term value for our stockholders Pay Element Objectives CEO Pay Mix (2019) ▪ Provides a base leve
Slide 15: Compensation Program Reflects Stockholder Feedback
Compensation Program Reflects Stockholder Feedback Informed by stockholder feedback from prior outreach discussions, the Compensation Committee made the following changes to its 2019 or 2020 executive compensation programs: Restricted Stock Units (RSUs) • Company did not issue any RSUs to named exec
Slide 16: Strong Governance And Compensation Practices
Strong Governance And Compensation Practices Our Board has adopted strong governance and compensation practices to provide stockholders with meaningful rights and to help ensure long-term focus and appropriate levels of risk-taking Governance Compensation ► Annual election of directors ► Pay-for-per
Baxter International — Investor Presentation (September 2020) on 6ix